Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6441444 | 0.77 | CYP3A4 (0.41) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL1053930 | 0.75 | CYP1A2 (0.35) | CYP1A2CYP2A6TSHRTDP2NSD2 | |
| SCHEMBL258271 | 0.72 | CYP3A4 (0.39) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL10583579 | 0.72 | CYP3A4 (0.34) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL13905953 | 0.70 | ACHE (0.38) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL8441919 | 0.69 | PON1 (0.33) | — | |
| SCHEMBL6403160 | 0.68 | CYP3A4 (0.46) | CYP3A4ALOX15TSHR | |
| SCHEMBL1157142 | 0.68 | CYP3A4 (0.46) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL237637 | 0.68 | CYP3A4 (0.35) | CYP3A4HTR2BCYP2A6 | |
| SCHEMBL30394748 | 0.68 | NOTUM (0.37) | CYP3A4CHRM1ALOX15MAOATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4116338-B1 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | LIFE TECHNOLOGIES CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-12122859-B2 | Hydrophilic polymeric particles and methods for making and using same | LIFE TECHNOLOGIES AS (NO) | 2024-10-22 | — | — | US | disclosed |
| EP-3702383-B1 | POLYMER SUBSTRATES FORMED FROM CARBOXY FUNCTIONAL ACRYLAMIDE | LIFE TECHNOLOGIES CORP (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20230167210-A1 | Hydrophilic Polymeric Particles and Methods for Making and Using Same | Life Technologies Corporation | 2023-06-01 | — | — | US | disclosed |
| US-11572427-B2 | Hydrophilic polymeric particles and methods for making and using same | Life Technologies Corporation (US) | 2023-02-07 | — | — | US | disclosed |
| EP-4116338-A1 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | Life Technologies Corporation (US) | 2023-01-11 | — | — | EP | disclosed |
| EP-2812360-B1 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | LIFE TECHNOLOGIES CORP (US) | 2022-08-31 | — | — | EP | disclosed |
| US-20210155726-A1 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING AND USING SAME | LIFE TECHNOLOGIES AS (NO) | 2021-05-27 | — | — | US | disclosed |
| US-10947333-B2 | Hydrophilic polymeric particles and methods for making and using same | Life Technologies Corporation (US) | 2021-03-16 | — | — | US | disclosed |
| EP-3702383-A1 | POLYMER SUBSTRATES FORMED FROM CARBOXY FUNCTIONAL ACRYLAMIDE | Life Technologies Corporation (US) | 2020-09-02 | — | — | EP | disclosed |
| US-9156925-B2 | Hydrophilic polymeric particles and methods for making and using same | Life Technologies Corporation (US) | 2015-10-13 | — | — | US | disclosed |
| US-9139665-B2 | Hydrophilic polymeric particles and methods for making and using same | Life Technologies Corporation (US) | 2015-09-22 | — | — | US | disclosed |
| US-9139666-B2 | Hydrophilic polymeric particles and methods for making and using same | Life Technologies Corporation (US) | 2015-09-22 | — | — | US | disclosed |
| EP-2812360-A2 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | Life Technologies Corporation (US) | 2014-12-17 | — | — | EP | disclosed |
| US-20140142254-A1 | Hydrophilic Polymeric Particles and Methods for Making and Using Same | LIFE TECHNOLOGIES AS (NO) | 2014-05-22 | — | — | US | disclosed |
| US-20140073715-A1 | Hydrophilic Polymeric Particles and Methods for Making and Using Same | LIFE TECHNOLOGIES AS (NO) | 2014-03-13 | — | — | US | disclosed |
| US-20140073738-A1 | Hydrophilic Polymeric Particles and Methods for Making and Using Same | LIFE TECHNOLOGIES AS (US) | 2014-03-13 | — | — | US | disclosed |
| US-20130210991-A1 | Hydrophilic Polymeric Particles and Methods for Making and Using Same | Life Technologies Corporation (US) | 2013-08-15 | — | — | US | disclosed |
| WO-2013119936-A2 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | Life Technologies Corporation (US) | 2013-08-15 | — | — | WO | disclosed |
| US-5705302-A | MULTILAYER ELEMENT WITH OPTICALLY TRANSPARENT SUBSTRATE, A CONDUCTIVE LAYER, COLOR LAYER WITH RED GREEN AND BLUE PIXELS | SEIKO EPSON CORPORATION (JP) | 1998-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167210-A1 | Hydrophilic Polymeric Particles and Methods for Making and Using Same | CD44, CD68, MTDH | CYP3A4 3654/4885CHRM1 2174/4885ALOX15 1267/4885 |
| US-10947333-B2 | Hydrophilic polymeric particles and methods for making and using same | CD44, CD68, MTDH | CYP3A4 3654/4885CHRM1 2174/4885ALOX15 1267/4885 |
| US-20210155726-A1 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING AND USING SAME | CD44, CD68, MTDH | CYP3A4 3654/4885CHRM1 2174/4885ALOX15 1267/4885 |
| US-11572427-B2 | Hydrophilic polymeric particles and methods for making and using same | CD44, CD68, MTDH | CYP3A4 3654/4885CHRM1 2174/4885ALOX15 1267/4885 |
| US-12122859-B2 | Hydrophilic polymeric particles and methods for making and using same | CD44, CD68, MTDH | CYP3A4 3654/4885CHRM1 2174/4885ALOX15 1267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.